<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109077">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01668264</url>
  </required_header>
  <id_info>
    <org_study_id>1000017963</org_study_id>
    <nct_id>NCT01668264</nct_id>
  </id_info>
  <brief_title>Imaging Assessment of Diastolic Function</brief_title>
  <official_title>Combined Echocardiographic and MRI Assessment of Diastolic Function in Patients With Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diastolic function is poorly studied in children with congenital heart disease. This is
      mainly due to the lack of validated techniques. Cardiac MRI offers two advantages compared
      to echocardiography: 1. accurate measurements of ventricular volumes and mass; 2. tissue
      characterization. The main advantage of echocardiography is a better temporal resolution
      which allows the study of short events like early relaxation. Overall there is a lack of
      studies correlating different echocardiographic and MRI parameters of heart function in
      pediatric populations with congenital or acquired heart diseases. This study will address
      specific questions on specific groups of patients that might bring more insight into chamber
      interaction and cardiac function. This study hypothesizes the following:

        -  Atrial enlargement is a marker of chronic increase in filling pressures and 3D echo
           might be the best method for follow-up.

        -  Cardiac remodeling associated with chronic loading results in changes in diastolic
           properties related to changes in cardiac mass and volume. This is related to changes in
           cardiac mechanics influencing diastolic parameters. Especially the influence on
           twisting and untwisting will be studied.

        -  Regional myocardial fibrosis and scarring may account for regional systolic and
           diastolic dysfunction with possible prognostic impact
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Atrial Volumes</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure right and left atrial volumes by 2D and 3D echo and correlate the different echocardiographic measurements with MRI. This will allow identifying the most accurate measurement which can be used in clinical practice.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess Ventricular Volumes</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess ventricular volumes and mass and calculate mass/volume ratio. Study the effect of ventricular remodeling on myocardial mechanics especially twisting and untwisting. Relate these changes to evaluation of diastolic function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Scarring</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess the presence of myocardial scarring in specific populations with congenital heart disease and correlate the findings with regional and global systolic and diastolic dysfunction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Magnetic Resonance Imaging (MRI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Echocardiograph</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiograph</intervention_name>
    <arm_group_label>Magnetic Resonance Imaging (MRI)</arm_group_label>
    <arm_group_label>Echocardiograph</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <arm_group_label>Magnetic Resonance Imaging (MRI)</arm_group_label>
    <arm_group_label>Echocardiograph</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with tetralogy of Fallot post repair, transposition of great arteries
             after arterial switch operation, aortic valvulopathy (aortic stenosis and aortic
             regurgitation), coarctation of the aorta and cardiomyopathy, who are planned to
             undergo a cardiac MRI will be eligible.

          -  Informed consent

        Exclusion Criteria:

          -  Lack of informed consent

          -  Need for general anesthesia

          -  Similar contraindications as for a clinical MRI study apply.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Mertens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luc Mertens, MD</last_name>
    <phone>(416)813-7418</phone>
    <email>luc.mertens@sickkids.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Mertens, MD</last_name>
      <phone>(416)813-7418</phone>
      <email>luc.mertens@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Luc Mertens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andreea Dragulescu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars Grosse-Wortmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shi-Joon Yoo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edgar Jaeggi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Friedberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 14, 2012</lastchanged_date>
  <firstreceived_date>August 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatrics</keyword>
  <keyword>Congenital Heart Disease</keyword>
  <keyword>Diastolic Function</keyword>
  <keyword>Echocardiograph</keyword>
  <keyword>MRI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
